510(k) device
ProNephro AKI (NGAL)
Bioporto Diagnostic, Inc. · Acute Kidney Injury Test System (PIG, Class II) · First FDA decision Dec 7, 2023, newest Dec 7, 2023Kidney failure and dialysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
0
Naming "ProNephro AKI"
MAUDE reports
0
Brand "ProNephro AKI", since 2015
PubMed studies
1
Mentioning "ProNephro AKI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ProNephro AKI (NGAL)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- ProNephro AKI (NGAL)Breakthrough510(k)
K232761 · Decided Dec 7, 2023 · 90 days after receipt
Device type: Acute Kidney Injury Test System (PIG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ProNephro AKI", any status and sponsor, newest update first.
No registered device study names "ProNephro AKI".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ProNephro AKI", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PIG
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2937-2026 · Started May 18, 2026 · Posted by FDA Aug 12, 2026
Reason given: The use of a non-validated rework process for assay reagents which could lead to missed diagnosis of renal disease, inappropriate treatment decisions, or inappropriate monitoring of renal disease in intended users.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Acute Kidney Injury Test System (PIG)
Published research
The most relevant PubMed records for "ProNephro AKI"[tiab]. The summary above synthesizes these.
- Validation of an assay for NGAL in a pediatric population.
Bithi N, Ibrahim RB, Tam EL, et al. · Pract Lab Med · 2025
Other devices of this type
Also filed under product code PIG.
- NEPHROCHECK Test SystemAstute Medical, Inc. · De Novo 2017
- Vidas NephrocheckBiomérieux SA · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.